1. Home
  2. EXFY vs CUE Comparison

EXFY vs CUE Comparison

Compare EXFY & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expensify Inc.

EXFY

Expensify Inc.

HOLD

Current Price

$1.15

Market Cap

110.9M

Sector

Technology

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$29.46

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXFY
CUE
Founded
2008
2014
Country
United States
United States
Employees
117
29
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.9M
124.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
EXFY
CUE
Price
$1.15
$29.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.50
$120.00
AVG Volume (30 Days)
684.0K
119.5K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.11
EPS
N/A
N/A
Revenue
$142,101,000.00
$27,466,000.00
Revenue This Year
$0.42
N/A
Revenue Next Year
$0.11
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.06
195.75
52 Week Low
$0.69
$0.17
52 Week High
$2.55
$41.42

Technical Indicators

Market Signals
Indicator
EXFY
CUE
Relative Strength Index (RSI) 59.53 62.97
Support Level $0.77 $0.30
Resistance Level $1.19 $41.42
Average True Range (ATR) 0.03 2.91
MACD -0.01 -0.02
Stochastic Oscillator 50.00 80.56

Price Performance

Historical Comparison
EXFY
CUE

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app. Small and medium-sized businesses (SMBs) are the cornerstone of the global economy, making up almost all businesses and the majority of employment in Organization for Economic Co-operation and Development (OECD) member countries.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: